Showing results (821-830 of 1,182) with videos related to
Sort By:
Pageof 119
Applied Health Economics and Health Policy|August 7, 2022
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from ChinaZiping Ye, Raela Abduhilil, Jiaxin Huang, et al.Applied Health Economics and Health Policy|August 21, 2022
Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic ResistanceSofie Larsson, Charlotta Edlund, Pontus Nauclér, et al.Applied Health Economics and Health Policy|March 18, 2023
Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims DataJohannes Wendl, Andreas Simon, Martin Kistler, et al.Applied Health Economics and Health Policy|February 28, 2023
Modelling Methods of Economic Evaluations of HIV Testing Strategies in Sub-Saharan Africa: A Systematic ReviewArthi Vasantharoopan, Victoria Simms, Yuyen Chan, et al.Applied Health Economics and Health Policy|November 14, 2022
The Role of Mental Health on Workplace Productivity: A Critical Review of the LiteratureClaire de Oliveira, Makeila Saka, Lauren Bone, et al.Applied Health Economics and Health Policy|October 28, 2025
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview StudyVittoria Ardito, Helen Banks, Rosanna TarriconeApplied Health Economics and Health Policy|October 10, 2025
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation ProgramMichael J DiStefano, R Brett McQueen, Hanke Zheng, et al.Applied Health Economics and Health Policy|June 23, 2020
Evaluating Equity in Health Financing Using Benefit Incidence Analysis: A Framework for Accounting for Quality of CareAugustine Asante, Nicola Man, Virginia WisemanApplied Health Economics and Health Policy|September 17, 2025
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease SeverityMarios Athanasios Loupas, Kostas Athanasakis, Dimitris ZavrasApplied Health Economics and Health Policy|August 12, 2021
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United KingdomHan Geul Byun, Minyoung Jang, Hyun Kyeong Yoo, et al.Pageof 119